7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid>98.0%(HPLC)(T)1g

Tetrachlorosilane>98.0%(T)500g

4,6-Dichloropyridine-2-carbonitrile, 95.0%, 10g

2-(Methoxymethyl)pyridine, 95.0%, 25g

1-(3-Fluoropyridin-2-yl)ethan-1-ol, 95+%, 10g

3-Hydroxy-2-pyridinecarboxylic acid methyl ester, 95.0%, 100g

(3,5-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 98%, 5g

(S)-3-(((2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)butanoyl)oxy)-2-((tert-butoxycarbonyl)amino)propanoic acid, 98%, 5g

3-Bromo-2-formylbenzoic acid, 97%, 500mg

Dimethyl (3,3-difluoro-2-oxoheptyl)phosphonate, 95.0%, 5g

N-Cyclopropyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide, 96%, 5g

4-Dimethylaminopiperidine, 98.0%, 5g

anti-Glial Fibrillary Acidic Protein mouse monoclonal, GF 12.24, 1 ml